Works in Neuro-Oncology, 2023, Vol 25, Issue 1


Results: 24
    1
    2

    Reviewer Lists.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 214, doi. 10.1093/neuonc/noac277
    Publication type:
    Article
    3

    Forthcoming Meetings.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 217, doi. 10.1093/neuonc/noac259
    Publication type:
    Article
    4
    5
    6

    road we travel.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 135, doi. 10.1093/neuonc/noac235
    By:
    • Nabors, Burt
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 4, doi. 10.1093/neuonc/noac207
    By:
    • Miller, Julie J;
    • Castro, L Nicolas Gonzalez;
    • McBrayer, Samuel;
    • Weller, Michael;
    • Cloughesy, Timothy;
    • Portnow, Jana;
    • Andronesi, Ovidiu;
    • Barnholtz-Sloan, Jill S;
    • Baumert, Brigitta G;
    • Berger, Mitchell S;
    • Bi, Wenya Linda;
    • Bindra, Ranjit;
    • Cahill, Daniel P;
    • Chang, Susan M;
    • Costello, Joseph F;
    • Horbinski, Craig;
    • Huang, Raymond Y;
    • Jenkins, Robert B;
    • Ligon, Keith L;
    • Mellinghoff, Ingo K
    Publication type:
    Article
    15
    16

    European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL).

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 37, doi. 10.1093/neuonc/noac196
    By:
    • Hoang-Xuan, Khê;
    • Deckert, Martina;
    • Ferreri, Andrés J M;
    • Furtner, Julia;
    • Perez-Larraya, Jaime Gallego;
    • Henriksson, Roger;
    • Hottinger, Andreas F;
    • Kasenda, Benjamin;
    • Lefranc, Florence;
    • Lossos, Alexander;
    • McBain, Catherine;
    • Preusser, Matthias;
    • Roth, Patrick;
    • Rudà, Roberta;
    • Schlegel, Uwe;
    • Soffietti, Riccardo;
    • Soussain, Carole;
    • Taphoorn, Martin J B;
    • Touitou, Valérie;
    • Weller, Michael
    Publication type:
    Article
    17
    18

    Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 185, doi. 10.1093/neuonc/noac147
    By:
    • Magalhães, Taciani de Almeida;
    • Cruzeiro, Gustavo Alencastro Veiga;
    • Sousa, Graziella Ribeiro de;
    • Englinger, Bernhard;
    • Nagano, Luis Fernando Peinado;
    • Ancliffe, Mathew;
    • Silva, Keteryne Rodrigues da;
    • Jiang, Li;
    • Gojo, Johannes;
    • Liu, Yulu Cherry;
    • Carline, Brooke;
    • Kuchibhotla, Mani;
    • Saggioro, Fabiano Pinto;
    • Marie, Suely Kazue Nagahashi;
    • Oba-Shinjo, Sueli Mieko;
    • Yunes, José Andres;
    • Queiroz, Rosane Gomes de Paula;
    • Scrideli, Carlos Alberto;
    • Endersby, Raelene;
    • Filbin, Mariella G
    Publication type:
    Article
    19

    Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 157, doi. 10.1093/neuonc/noac144
    By:
    • Pérez-García, José Manuel;
    • Batista, Marta Vaz;
    • Cortez, Patricia;
    • Ruiz-Borrego, Manuel;
    • Cejalvo, Juan Miguel;
    • de la Haba-Rodriguez, Juan;
    • Garrigós, Laia;
    • Racca, Fabricio;
    • Servitja, Sonia;
    • Blanch, Salvador;
    • Gion, María;
    • Nave, Monica;
    • Fernández-Abad, María;
    • Martinez-Bueno, Alejandro;
    • Llombart-Cussac, Antonio;
    • Sampayo-Cordero, Miguel;
    • Malfettone, Andrea;
    • Cortés, Javier;
    • Braga, Sofía
    Publication type:
    Article
    20

    Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 54, doi. 10.1093/neuonc/noac141
    By:
    • Messinger, Dana;
    • Harris, Micah K;
    • Cummings, Jessica R;
    • Thomas, Chase;
    • Yang, Tao;
    • Sweha, Stefan R;
    • Woo, Rinette;
    • Siddaway, Robert;
    • Burkert, Martin;
    • Stallard, Stefanie;
    • Qin, Tingting;
    • Mullan, Brendan;
    • Siada, Ruby;
    • Ravindran, Ramya;
    • Niculcea, Michael;
    • Dowling, Abigail R;
    • Bradin, Joshua;
    • Ginn, Kevin F;
    • Gener, Melissa A H;
    • Dorris, Kathleen
    Publication type:
    Article
    21

    Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 146, doi. 10.1093/neuonc/noac139
    By:
    • Fuente, Macarena I de la;
    • Colman, Howard;
    • Rosenthal, Mark;
    • Tine, Brian A Van;
    • Levacic, Danijela;
    • Walbert, Tobias;
    • Gan, Hui K;
    • Vieito, Maria;
    • Milhem, Mohammed M;
    • Lipford, Kathryn;
    • Forsyth, Sanjeev;
    • Guichard, Sylvie M;
    • Mikhailov, Yelena;
    • Sedkov, Alexander;
    • Brevard, Julie;
    • Kelly, Patrick F;
    • Mohamed, Hesham;
    • Monga, Varun
    Publication type:
    Article
    22

    Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 199, doi. 10.1093/neuonc/noac132
    By:
    • Yeo, Kee Kiat;
    • Alexandrescu, Sanda;
    • Cotter, Jennifer A;
    • Vogelzang, Jayne;
    • Bhave, Varun;
    • Li, Marilyn M;
    • Ji, Jianling;
    • Benhamida, Jamal K;
    • Rosenblum, Marc K;
    • Bale, Tejus A;
    • Bouvier, Nancy;
    • Kaneva, Kristiyana;
    • Rosenberg, Tom;
    • Lim-Fat, Mary Jane;
    • Ghosh, Hia;
    • Martinez, Migdalia;
    • Aguilera, Dolly;
    • Smith, Amy;
    • Goldman, Stewart;
    • Diamond, Eli L
    Publication type:
    Article
    23

    Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 123, doi. 10.1093/neuonc/noac099
    By:
    • Omuro, Antonio;
    • Brandes, Alba A;
    • Carpentier, Antoine F;
    • Idbaih, Ahmed;
    • Reardon, David A;
    • Cloughesy, Timothy;
    • Sumrall, Ashley;
    • Baehring, Joachim;
    • van den Bent, Martin;
    • Bähr, Oliver;
    • Lombardi, Giuseppe;
    • Mulholland, Paul;
    • Tabatabai, Ghazaleh;
    • Lassen, Ulrik;
    • Sepulveda, Juan Manuel;
    • Khasraw, Mustafa;
    • Vauleon, Elodie;
    • Muragaki, Yoshihiro;
    • Giacomo, Anna Maria Di;
    • Butowski, Nicholas
    Publication type:
    Article
    24

    Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 137, doi. 10.1093/neuonc/noac137
    By:
    • Rogers, C Leland;
    • Pugh, Stephanie L;
    • Vogelbaum, Michael A;
    • Perry, Arie;
    • Ashby, Lynn S;
    • Modi, Jignesh M;
    • Alleman, Anthony M;
    • Barani, Igor J;
    • Braunstein, Steve;
    • Bovi, Joseph A;
    • Groot, John F de;
    • Whitton, Anthony C;
    • Lindhorst, Scott M;
    • Deb, Nimisha;
    • Shrieve, Dennis C;
    • Shu, Hui-Kuo;
    • Bloom, Beatrice;
    • Machtay, Mitchell;
    • Mishra, Mark V;
    • Robinson, Clifford G
    Publication type:
    Article